Riskpilot← Back to searchSign inGet full accessCELLULOSEVEGEN 2 AS
ASActiveOrg 992054549Hvervenmoveien 49, 3511 HønefossRental and operating of own or leased real estate · NACE 6820Est. 20070 employees
Revenue 2024
NOK 3,9M
+3% vs 2023
EBITDA margin
90.6%
+2% vs 2023
Equity ratio
19.7%
Financial strength
Net profit 2024
NOK 2,1M
0% vs 2023
| Revenue | NOK 3,9M | +3% |
| EBITDA | NOK 3,5M | +2% |
| Net profit | NOK 2,1M | +0% |
| Total assets | NOK 12,3M | +5% |
| Equity | NOK 2,4M | -2% |
| Employees | 0 | — |
Legal name
CELLULOSEVEGEN 2 AS
Org number
992054549
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
22. desember 2007
Share capital
NOK 1 290 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Eie, utvikle og drifte fast eiendom, samt eie aksjer og andeler i andre selskap.
Address
Hvervenmoveien 49, 3511 Hønefoss
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 158 | 2 320 | 3 016 | 3 064 | 3 125 | 3 217 | 3 249 | 3 330 | 3 378 | 3 425 | 3 521 | 3 733 | 3 857 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 1 629 | 2 206 | 2 858 | 2 822 | 2 877 | 2 969 | 3 003 | 3 043 | 3 053 | 3 161 | 3 244 | 3 424 | 3 493 |
| Depreciation & amort. | −0 | −514 | −332 | −332 | −332 | −333 | −333 | −333 | −333 | −333 | −333 | −333 | −333 |
| EBIT | 1 629 | 1 692 | 2 526 | 2 490 | 2 545 | 2 636 | 2 669 | 2 710 | 2 720 | 2 828 | 2 910 | 3 091 | 3 160 |
| Net financials | −583 | −433 | −357 | −289 | −287 | −341 | −187 | −199 | −251 | −138 | −222 | −330 | −409 |
| Profit before tax | 1 046 | 1 259 | 2 170 | 2 201 | 2 257 | 2 295 | 2 482 | 2 512 | 2 469 | 2 689 | 2 688 | 2 761 | 2 751 |
| Tax | 294 | 354 | 586 | 577 | 554 | 540 | 559 | 553 | 543 | 592 | 591 | 607 | 605 |
| Net profit | 752 | 905 | 1 584 | 1 624 | 1 703 | 1 755 | 1 923 | 1 959 | 1 926 | 2 098 | 2 097 | 2 154 | 2 145 |
| Item | 2008 | 2009 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 12 921 | 11 800 | 14 180 | 14 682 | 17 231 | 12 638 | 12 286 | 12 758 | 13 203 | 13 764 | 11 173 | 11 755 | 12 309 |
| Equity | 2 099 | 3 004 | 1 998 | 2 146 | 2 265 | 2 361 | 2 435 | 2 477 | 2 499 | 2 504 | 2 492 | 2 465 | 2 425 |
| Long-term debt | 10 200 | 8 400 | 10 102 | 10 386 | 12 723 | 7 953 | 7 309 | 7 686 | 8 112 | 8 423 | 5 818 | 6 326 | 6 917 |
| Short-term debt | 622 | 396 | 2 079 | 2 149 | 2 243 | 2 324 | 2 542 | 2 595 | 2 592 | 2 838 | 2 864 | 2 964 | 2 967 |
| Total debt | 10 822 | 8 796 | 12 181 | 12 536 | 14 966 | 10 277 | 9 851 | 10 281 | 10 704 | 11 260 | 8 681 | 9 290 | 9 884 |
EBITDA margin
90.6%
This company
15.8%
Market median
+473% vs market
20082024
Equity ratio
19.7%
This company
38.2%
Market median
-48% vs market
20082024
Return on equity
88.5%
This company
18.4%
Market median
+381% vs market
20082024
Net profit margin
55.6%
This company
8.1%
Market median
+586% vs market
20082024
Asset turnover
0.31×
This company
1.12×
Market median
-72% vs market
20082024
Debt / equity
4.08×
This company
0.62×
Market median
-558% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Aka As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Stærkebye As
CELLULOSEVEGEN 2 AS Board members of CELLULOSEVEGEN 2 AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rolf Hammerengen | Board of Directors | 0 companies |
| Jane Kim Gravbråten | Chairman | 0 companies |